A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving ...

A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving acute myeloid leukemia (AML), an aggressive blood cancer affecting the bone ...

Structural nanomedicine — what helped give us the COVID vaccine — may now be the key to a potent blood cancer treatment that’s had remarkable early results.

Acute myeloid leukemia (AML) is an aggressive form of blood cancer. It affects people of all ages but is most common in those over 65. Around 150 people are diagnosed with the disease each year in ...

A new study has revealed that a “common” ingredient found in a string of popular energy drinks could elevate the risk of blood cancers. US researchers have found that taurine, an amino acid often ...

PIKE COUNTY, Ohio (WKRC) - After five years and dozens of remarkable investigative stories in our “Fallout” investigation that revealed contamination, high rates of cancer, and death, hundreds of ...

Dr. Ashkan Emadi, principal investigator of a first-in-world phase 2 clinical trial evaluating subcutaneous Blincyto (blinatumomab) for CD19-positive mixed phenotype acute leukemia, sat down for an ...

Cancer cells are metabolic opportunists, bending every pathway to fuel unchecked growth. Now UCLA scientists show that a single protein—Insulin-like Growth Factor 2 mRNA-Binding Protein 3 ...

Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that seed cancer relapses, researchers report. The aptamers -- short ...

CHARLESTON, S.C. (WCIV) — MUSC researchers at the Hollings Cancer center are making strides in new developments for leukemia treatment. Sophie Paczesny, M.D., Ph.D., the principal investigator for ...